The Signal — DOE backs eight SMR companies with $94M while Cameco's flooded bridge cuts global uranium supply. Dual catalyst: demand acceleration + supply squeeze. Uranium squeeze imminent if logistics don't recover within 60 days.
Consensus: Bullish | Conviction: High
What's Moving
- Uranium spot / $LEU $UEC $UUUU — Supply crunch real; McArthur River (world's largest high-grade mine) halted; Key Lake reduced. History rhymes: 2004 Cigar Lake flooded, uranium rallied $20→$138/lb. (via @derekquick1)
- $NVO (Novo Nordisk) — GLP-1 oral adoption narrative building; same-day Amazon delivery removes friction. Market still chasing semis; pharma supercycle underpriced. (via @derekquick1)
- $BWXT $CEG — Direct beneficiaries of NELP (Nuclear Energy Launch Pad). Need capacity to build more reactors; supply-chain forges/manufacturers now in focus. (via @unomasreactor)
- Uranium conversion/enrichment — Won't scale 2-3x if uranium price does. Utilities won't pay 2-3x if backend costs stay flat. Margin arbitrage opportunity. (via @uraniuminsider)
- $SMR $OKLO — SMR thesis moving from R&D to deployment capital. Eight companies funded; orderbook acceleration next catalyst.
Blind Spot — Consensus ignores uranium market fragility: McArthur + Key Lake represent critical chokepoint; supply recovery timeline is unknown (1-3 months per analysts). If prolonged, utilities panic-buy at any price. Also: GLP-1 oral scaling (Amazon + insurance expansion) could rival uranium as overlooked macro theme. Market is captive to AI/semis narrative; positioning in uranium/pharma still lightweight despite tailwinds.
One Actionable Idea — Long uranium spot + $LEU sub-$4 entry if McArthur Bridge repair extends beyond 60 days; pair with small SMR/nuclear infrastructure play ($BWXT) for execution upside. Avoid leverage; volatility will be extreme both ways.
Sources: @derekquick1 (uranium squeeze conviction, $NVO early adoption play), @uraniuminsider (supply mechanics), @govnuclear (SMR funding catalyst), @unomasreactor (supply-chain beneficiaries)